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More than 30 human genetic diseases are linked to tri-nucleotide repeat expansions.
There is no known mechanism that explains repeat expansions in full, but changes
in the epigenetic state of the associated locus has been implicated in the disease
pathology for a growing number of examples. A comprehensive comparative analysis
of the genomic features associated with diverse repeat expansions has been lacking.
Here, in an effort to decipher the propensity of repeats to undergo expansion and result
in a disease state, we determine the genomic coordinates of tri-nucleotide repeat tracts
at base pair resolution and computationally establish epigenetic profiles around them.
Using three complementary statistical tests, we reveal that several epigenetic states are
enriched around repeats that are associated with disease, even in cells that do not harbor
expansion, relative to a carefully stratified background. Analysis of over one hundred cell
types reveals that epigenetic states generally tend to vary widely between genic regions
and cell types. However, there is qualified consistency in the epigenetic signatures of
repeats associated with disease suggesting that changes to the chromatin and the DNA
around an expanding repeat locus are likely to be similar. These epigenetic signatures
may be exploited further to develop models that could explain the propensity of repeats
to undergo expansions.
Keywords: short tandem repeat, bioinformatics, epigenetics, histone modification, DNA methylation, genome
sequence
1. INTRODUCTION
Expansion of short tandem repeats (STRs) in human genes has been shown to cause a range of
debilitating neurological diseases (Kovtun and McMurray, 2008; Dion and Wilson, 2009; Cohen-
Carmon and Meshorer, 2012). Repeat expansions can be observed in both germline and somatic
tissues, but the factors that underlie the expansion of short tandem repeats in general are poorly
understood. Changes in epigenetic status surrounding repeat expansions have been shown to be
critical for the associated disease pathology in diseases such as Friedreich ataxia (Nakamori and
Thornton, 2010; Evans-Galea et al., 2012; Soragni et al., 2014). It has also been suggested that
these changes could modulate instability of STRs (Nichol and Pearson, 2002; Gorbunova et al.,
2004; Libby et al., 2008; Debacker et al., 2012; Gannon et al., 2012). The Roadmap Epigenomics
project (Roadmap Epigenomics Consortium et al., 2015) performed genome-wide epigenetic
assays for primary cells and tissue types at unprecedented scale, and offers a timely opportunity
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to computationally explore the epigenetic context of tri-
nucleotide repeats (TNRs) and their association with repeat
expansion.
Based on their relative position within a gene, broadly, TNRs
can be grouped as “coding” (exonic), and “non-coding” (intronic,
intergenic, etc.). The former class includes almost exclusively
CAG repeats that lead to polyglutamine stretches in proteins
observed in Huntington’s disease and most of the spinocerebellar
ataxias. In contrast, repeat expansions in introns, 5′ and 3′ UTR
regions of genes, are of different types, exemplified by the GAA
repeat expansion in Friedreich ataxia, fragile X syndrome and
myotonic dystrophy(Lopez-Castel et al., 2010).
A comparison of the triplet repeats (≥ 6 repeat units) across
the human genome revealed that more than 10,000 tandem
repeats are present within the genic regions (Willadsen et al.,
2013). However, the repeat expansions have been reported in
only a handful of cases representing approximately 30 disease
conditions, even though in theory all the repeats may have
the potential to undergo expansion. This raises the question as
to what factors determine the propensity of a given repeat to
undergo expansion.
In recent years, experiments on relevant TNR disease model
cell types point to an association of heterotransplantation
with both coding and non-coding repeat expansions (Dion
and Wilson, 2009; Cohen-Carmon and Meshorer, 2012). The
formation of heterochromatin appears to be effected via histone
modifications as well as DNA methylation at CpG islands at or
very near the repeat expansions. The transition into a repressed
state is a unifying aspect associated with triplet expansions
raising the question, does an epigenetic environment exist that
is unique to expanded, disease-associated TNRs? It also raises
an interesting possibility of epigenetic features governing the
propensity of a given repeat to undergo expansions. We therefore
considered whether epigenetic features discerned in normal,
healthy cells can help explain and predict if a TNR can, under
some circumstance, become unstable and cause disease.
To answer these questions we sought to distinguish
between disease-associated TNRs (DA-TNRs), from a set of
background TNRs (bg-TNRs; all TNRs, not distinguishing
between expanding and those that cause disease) to assess
whether we could arrive at common principles. Even though
the underlying genes have been cloned for several triplet
expansion diseases, a comprehensive dataset with genomic
co-ordinates has not been compiled so far, which is essential for
the computational exploration of common principles. To achieve
this, we first recorded canonical genomic coordinates of DA-
TNRs at a base pair level. Having the exact locations to what we
refer to as a foreground set, enabled us to precisely link genomic
properties to the repeat tract (e.g., histone acetylation and
methylation or DNA methylation patterns), and to statistically
evaluate their association with repeats en masse, i.e., in relation
to a background set.
In this paper, we test which epigenetic marks are enriched
for (grouped) repeat loci of interest. We develop three
complementary statistical tests to analyse the typical epigenetic
context of DA-TNRs and compare them with bg-TNRs, stratified
by sequence composition and genic location. This stratification
allows us to compare the epigenetic patterns statistically, across a
spectrum of cell types, that do not harbor expansions (Roadmap
Epigenomics Consortium et al., 2015). Specifically, we stratify
repeats by their sequence composition (e.g., CAG), their location
in the gene (exon, intron, 5′ UTR and 3′ UTR) or a combination
of these two features (e.g., exonic CAG). This paper shows that
the expansion-prone repeats differ from random set of repeats in
their epigenetic profiles, which suggests that certain epigenetic
profiles could be associated with an increased propensity for
repeats to undergo expansion.
2. MATERIALS AND METHODS
2.1. Determining the Genomic
Co-ordinates of Triplet Repeats Associated
with Repeat Expansion Diseases
Wedetermined the genomic location for 32 known tri-nucleotide
repeats associated with disease, relative to human genome build
19 (hg19; UCSC) and the 2009 human reference sequence
(GRCh37; NCBI). The position of each disease gene was obtained
through the UCSC genome browser and when multiple variants
were encountered, the minimum and maximum positions were
used. We used RefSeq annotation track on UCSC table browser
to generate the gene sequence separated into introns, exons and
UTRs. A manual search was carried out to locate each repeat and
confirm its position in an exon, intron or UTR region (genic
annotation). Where possible, repeat locations were confirmed
using the ZIP-seq database of CAG repeats (Xu et al., 2014). ZIP-
seq recovered locations for eleven of seventeen CAG DA-TNRs.
The location data for all DA-TNRs are shown in Table 1 but
are also made available in the Supplementary Material both as a
spreadsheet, which contains references to primary publications,
and as a standard BED file, which will allow users to view
locations in the UCSC Genome Browser (http://genome.ucsc.
edu) and process its content using most genome sequence tools
(e.g., BEDTOOLS).
We made use of both computationally deciphered TNRs
from genome sequences as well as experimentally confirmed
TNRs as a statistical background (bg-TNRs) to DA-TNRs. The
“computationally deciphered” background was constructed by
scanning the whole human genome using Tandem Repeats
Finder (Benson, 1999) to identify all repeats which share either
genic annotation or sequence repeat unit with one or more
DA-TNRs. Zinc finger protein-based immunoprecipitation and
sequencing (ZIP-seq) has allowed for genome-wide analysis of
TNRs leading to development of a database of CAG repeats
located in genes throughout the human genome (Xu et al., 2014).
The ZIP-seq database has higher sensitivity than Tandem Repeats
Finder andmakes up our experimentally determined background
of TNRs of length ≥ 3 repeat units.
2.2. Selection of Epigenetic Marks and
Data Sets
To start with, we selected a subset of genomic signatures based
on their presumed or demonstrated roles in chromatin structure,
DNA replication or repair. Some of these marks have also
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TABLE 1 | Disease-associated tri-nucleotide repeats examined in this study.
Disease Disease ID Gene Locus (hg19) Repeat
CODING, POLY-GLU REPEATS
Spinobulbar muscular atrophy SBMA AR X:66765160 CAG
Huntington’s disease HD HTT 4:3076604 CAG
Dentatorubral-pallidoluysian atrophy DRPLA ATN1 12:7045880 CAG
Spinocerebellar ataxia type 1 SCA1 ATXN1 6:16327213 CAG
Spinocerebellar ataxia type 2 SCA2 ATXN2 12:112037083 CAG
Spinocerebellar ataxia type 3 SCA3 ATXN3 14:92537280 CAG
Spinocerebellar ataxia type 6 SCA6 CACNA1A 19:13318283 CAG
Spinocerebellar ataxia type 7 SCA7 ATXN7 3:63898362 CAG
Spinocerebellar ataxia type 17 SCA17 TBP 6:170870996 CAG
Potassium channel gene KCNN3 KCNN3 1:154841700 CAG
Amplified in breast cancer 1 AIB1 NCOA3 20:46279816 CAG
CODING, POLY-ALA REPEATS
Soluble programmed death-1 SPD1 HOXD13 2:176957782 GCG
Oculopharyngeal muscular dystrophy OPMD PABPN1 14:23790681 GCG
Associated with cleidocranial dysplasia, reduced bone mineral density and bone fracture CBFA1 CBFA1/ RUNX2 6:45390487 GCG
Holoprosencephaly ZIC2 ZIC2 13:100637703 GCG
Associated with hand-foot-genital syndrome HOXA13 HOXA13 7:27238886 GCG
Associated with blepharophimosis syndrome (BPES) FOXL2 FOXL2 3:138665094 GCG
Early infantile epileptic encephalopathy type 1 EIEE1 ARX X:25031140 GCG
CODING, POLY-ASP REPEATS
Associated with pseudochondroplasia (PSACH) & multiple epiphyseal dysplasia (MED) COMP COMP 19:18896872 GAC
NON-CODING REPEATS
Associated with Fuchs’ endothelial corneal dystrophy (FECD) CTG18.1 TCF4 18:53253401 CAG
Myotonic dystrophy type 1 DM1 DMPK 19:46273199 CAG
Friedreich ataxia FRDA FXN 9:71652203 GAA
Spinocerebellar ataxia type 8 SCA8 ATXN8OS 13:70681356 CAG
Spinocerebellar ataxia type 12 SCA12 PPP2R2B 5:146258400 CAG
Huntington’s disease-like 2 HDL2 JPH3 16:87637894 CAG
Not currently Associated with a phenotypic abnormality MAB21L1 MAB21L1 13:36050618 CAG
Candidate gene for autism spectrum disorders (ASDs) RELN RELN 7:103629939 GCG
Fragile X syndrome/Fragile X tremor ataxia syndrome FRAXA/ FXTAS FMR1 X:146993569 GCG
Folate-sensitive fragile site FRA10A FRA10A FRA10AC1 10:95462158 GCG
Fragile X syndrome FRAXE FMR2 X:147582153 GCG
Fragile X syndrome FRAXF FAM11A X:148713314 GCG
Folate-sensitive fragile site FRA11B FRA11B CBL2 11:119077000 GCG
Columns include disease, disease ID/abbreviation, causal or associated gene for the disease, the genomic location of the repeat, and the repeat sequence. The genomic location is
based on the reference hg19 and includes chromosome and starting position. See Supplementary Table 1 for references to supporting literature.
been associated with repeat instability (Libby et al., 2008; Dion
and Wilson, 2009; Nakamori and Thornton, 2010; Datta et al.,
2011; Cohen-Carmon and Meshorer, 2012; Debacker et al.,
2012; Volle and Delaney, 2012). The Roadmap Epigenomics
Project (Roadmap Epigenomics Consortium et al., 2015) and
the ENCODE Project (ENCODE Project Consortium, 2012)
encompass genome-wide high-quality data sets, which can be
utilized to answer specific questions statistically. We selected
nine genome-wide assays from the Roadmap Epigenomics
data repository, all of the histone modifications designated
as core epigenetic markers (available as ChIP-seq data for
111 tissues; see Table 2) and additional markers directly or
indirectly implicated in repeat instability (available in 37 or more
tissues; see Table 2), allowing an assessment that was relatively
unbiased in regards to tissue. We complemented this dataset
with genome-wide assays from the ENCODE data repository,
covering signatures from human embryonic stem cells (hESC).
For the ENCODE data, we used several markers for euchromatin,
heterochromatin and nucleosome occupancy, including DNase
I hypersensitivity assays (Crawford et al., 2006) and FAIRE
(Giresi et al., 2007). We also used a large number of ChIP-
seq data sets (Johnson et al., 2007) to probe binding events on
DNA and chromatin for a large number of relevant proteins
and their modifiers, including histone deacetylase (HDAC),
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TABLE 2 | Epigenetic marks analyzed in this study.
Assay Description Cell type Source
H3K4me1 A mark of regulatory elements associated with enhancer regions 111 ENCODE Project Consortium, 2012; Roadmap Epigenomics Consortium
et al., 2015
H3K4me3 A mark of regulatory elements associated with promoter regions 111 ENCODE Project Consortium, 2012; Roadmap Epigenomics Consortium
et al., 2015
H3K9me3 A repressive mark associated with heterochromatin regions 111 ENCODE Project Consortium, 2012; Roadmap Epigenomics Consortium
et al., 2015
H3K27me3 A repressive mark associated with Polycomb complex activity 111 ENCODE Project Consortium, 2012; Roadmap Epigenomics Consortium
et al., 2015
H3K36me3 An elongation mark associated with transcribed regions 111 ENCODE Project Consortium, 2012; Roadmap Epigenomics Consortium
et al., 2015
H3K9ac A mark of active regulatory elements associated with increased
activation of enhancer and promoter regions
44 ENCODE Project Consortium, 2012; Roadmap Epigenomics Consortium
et al., 2015
H3K27ac A mark of active regulatory elements associated with increased
activation of enhancer and promoter regions
82 ENCODE Project Consortium, 2012; Roadmap Epigenomics Consortium
et al., 2015
DNAm A mark associated with chromatin structure, silencing gene
expression and maintaining stability in repetitive DNA
40 Robertson, 2002; ENCODE Project Consortium, 2012; Roadmap
Epigenomics Consortium et al., 2015
DNase Denoting regions of accessible chromatin commonly associated
with regulatory DNA regions
37 ENCODE Project Consortium, 2012; Roadmap Epigenomics Consortium
et al., 2015
The columns include the standard abbreviation of the epigenetic mark, its biological description, the number of cell types explored in this study along with the data source.
the chromatin insulator CTCF, and an array of histone tail
modifications.
2.3. Statistical Enrichment Analysis
We developed three methods M1-M3 (summarized in Figure 1)
to analyse the epigenetic states around tri-nucleotide repeat
regions throughout the genome. We labeled each foreground
and background repeat with genomic region (exon, intron, 5′
UTR and 3′ UTR) and canonical tri-nucleotide repeat sequence
composition (amongst DA-TNRs there were only four found, of
ten possible: GAA.TTC, GAC.GTC, CAG.CTG, and GCG.CGC).
Grouped by composition and/or region, DA-TNRs could be
compared against similar repeats in the genome. We considered
the association of the epigenetic marks and their overlap in
individual cell types across repeats grouped by composition
and/or region (M1), the overlap of epigenetic marks with specific
individual repeats but with no attention to cell type (M2), and
the distance of an epigenetic mark from a repeat of interest (M3).
These three independent measures provide statistical robustness
for assessing the enrichment of the marks around expanded
repeats.
M1 determines the enrichment of an epigenetic mark
overlapping with a group of DA-TNRs. A contingency matrix
is created using counts of grouped DA-TNRs versus bg-TNRs
which overlap versus do not overlap an epigenetic mark.
Both DA- and bg-TNRs are stratified based on applicable
combinations of their genic annotation (exon, intron, 5′ and
3′ UTR) and/or repeat unit sequence (CAG, GCG, GAC, and
GAA). For a TNR (DA-TNR or bg-TNR) to be in a histone
modified state, M1 requires that either the start or the end
point is within the called ChIP-seq broad peak. For a TNR to
be DNA methylated, M1 requires that its start or end point is
within 200 base pairs of a methylated CpG. This more permissive
criterion accommodated that DNA methylation sites are shorter
than histone broad peaks.We also used DNase-seq narrow peaks,
and they were required to overlap with the TNR, to be counted as
a match.
M1 uses the Fisher Exact test on the contingency matrices
to assign a p-value for the resulting hypergeometric distribution
of counts, measuring the support for the over- or under-
enrichment of the epigenetic mark for the defined group of
DA-TNRs. (Over-enrichment means that DA-TNRs overlap with
the epigenetic mark to a greater extent than bg-TNRs. Under-
enrichment means that fewer DA-TNRs overlap with the mark
than expected from the counts of overlaps with bg-TNRs.) This
method is repeated independently for all different cell types and
epigenetic assays. We note the percent of cell types in which
the epigenetic mark is found overlapping with the group DA-
TNRs to an extent that cannot be explained by comparing against
a stratified but otherwise non-specific set of TNRs. This test
lacks statistical power for smaller groups of TNRs, e.g., there is
only one GAA DA-TNR, and four CAG DA-TNRs annotated
within 5′ UTRs. We left p-values uncorrected for multiple tests
to discern trends across all epigenetic maps for the same mark,
or across sub-sets of maps (say, for specific groups of cell
types).
M2 evaluates the enrichment of an epigenetic mark
overlapping a specific DA-TNR but across all cell types, relative
all bg-TNRs with identical sequence and genic annotation, also
sampled indiscriminatively from all cell types. The frequencies
accrued from bg-TNRs were used with a binomial test to
ascertain the cumulative probability of observing the actual
number (or more extreme) of overlaps between the specific
DA-TNR and the given epigenetic mark, across the now de-
identified cell types. The assumption that the epigenetic status
is independent of cell type, implicit in M2, enables us to look
at each individual DA-TNR statistically, but this violates the
understanding that cell fates are reflected in epigenetic states
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FIGURE 1 | A graphical representation of the three methods used to measure an enrichment of epigenetic environment around DA-TNRs. M1 measures
an association between a group of DA-TNRs and an epigenetic mark on basis of overlap within each cell type. M2 measures an association between a specific
DA-TNR and an epigenetic mark on basis of their overlap when cell type is ignored. M3 uses a distance from the centre of the repeat to the centre of the epigenetic
mark to measure enrichment. Each method makes different use of assays from available cell types, foregrounds and statistical tests to measure enrichment.
(Roadmap Epigenomics Consortium et al., 2015). To compensate
for multiple tests and this assumption, the p-value is corrected
conservatively before reported.
M3 evaluates for a single DA-TNR an enrichment based on
the distance to a given epigenetic mark or factor. For M3, a
distance was measured from the center of the repeat to the
center of the closest region labeled with the mark. We did not
stratify on length of repeat as this would reduce the size of
groups and therefore the statistical power. While longer repeats
increase the chance of overlap with epigenetic marks, DA-TNRs
did not demonstrate this tendency over that observed in bg-
TNRs, which are similarly length-distributed. For each mark, we
created a (kernel-estimated) density of log-transformed absolute
distances between (any) bg-TNRs and the corresponding, closest
occurrence of that mark. In this estimate, we included all bg-
TNRs that had identical sequence and genic annotation as the
DA-TNR of interest. From this density we computed a p-value
by inspecting the area. We only looked at the left (shorter
distance) tail of the density, which means we only assigned a
p-value to the DA-TNR of interest if proximity of mark was
enriched.
3. RESULTS
3.1. Expansion-Prone Triplet Repeats Have
Distinct Epigenetic Features
To compare the features of the disease-associated repeats, we
first compiled their reference genomic positions as described
above (see Table 1; Supplementary Table 1) and the positions
for a stratifiable background set. To assess the differences
between the DA-TNRs and bg-TNRs, we probed the enrichment
of histone modifications, DNA methylation and DNase I
hypersensitivity using the Roadmap Epigenomics project data
set (Roadmap Epigenomics Consortium et al., 2015) available
for multiple cell types. We generated epigenetic maps for all
cell types. Each map identifies all locations of that epigenetic
mark that overlap with a TNR in the cell type. The analysis
below thus involves a total of 758 epigenetic maps (see
Table 2).
Using the M1 method described earlier, for each epigenetic
map, we established the significance of the overlap of the
epigenetic mark and each grouped DA-TNR, independently for
each cell type. Table 3 shows the percentage of different cell
types in which DA-TNRs are either over- or under-enriched at
p ≤ 0.05 for the tested epigenetic mark. (A small p indicates that
the overlap established in bg-TNRs, fails to explain the overlap
between an epigenetic mark and DA-TNRs for the epigenetic
map.) In all our tests, the same trends are seen with either
Tandem Repeats Finder or ZIP-seq backgrounds. We provide
complete results for both backgrounds in the Supplementary
Tables and have focused on results based on Tandem Repeats
Finder below.
Our analyses revealed that DA-TNRs are more DNA
methylated than bg-TNRs are, in a majority of cell types (see
Table 3). This trend could be observed in both intronic and
exonic tandem repeats, in general for CAG repeats, and even for
the sole intronic GAA repeat for Friedreich ataxia. (For FRDA,
only one cell type “Brain angular gyrus” is not enriched for
DNA methylation.) Hence, it appears that positive methylation
status can be attributed to many DA-TNR loci (see Table 2).
However, repeats of either GCG or GAC, or those that fall in
3′ UTRs (see also Supplementary Table 1 “M1 DNAm”) form
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TABLE 3 | Percent of cell types that display over- or under-enrichment for specific epigenetic marks around DA-TNRs per M1 (see Figure 1) where TNRs
are grouped by either sequence and/or genic region.
Assay Sequence/Region
Any/ Any/ Any/ Any/ CAG/ GCG/ CAG/ CAG/ CAG/ CAG/ GCG/ GAA/
Exon (21) Intron (9) 5′UTR (11) 3′UTR (7) Any (14) Any (7) Exon (12) Intron (6) 5′UTR (4) 3′UTR (6) 5′UTR (6) Intron (1)
ACTIVE MARKS
H3K4me1 2 62 7 1 26 10 5 16 7 1 13 0
H3K4me3 65 100 46 0 95 0 53 82 77 52 0 7
H3K9ac 36 97 3 0 75 0 28 53 53 28 *6 0
H3K27ac 17 89 4 0 70 *6 18 32 48 12 *9 0
Any 32 95 32 1 69 1 17 33 40 6 1 0
REPRESSIVE MARKS
H3K9me3 4 10 7 6 *8 17 1 5 *3 1 20 0
H3K27me3 2 23 20 2 1 32 1 7 *1 0 51 0
H3K36me3 0 4 *11 0 12 2 0 1 14 1 2 0
Any 0 7 3 3 5 7 1 3 5 1 8 0
DNA METHYLATION
DNAm 68 100 50 3 90 5 65 85 85 33 3 98
DNA ACCESSIBILITY
DNase 46 100 41 0 92 0 41 57 65 38 *3 5
A row represents a specific epigenetic mark, or when marked “Any,” the union of all marks listed immediately above. Each column represents DA-TNRs grouped by sequence and/or
genic region (as indicated) with the absolute number of DA-TNRs in brackets. For each epigenetic mark and DA-TNR group, the percentage of cell types containing a statistically enriched
epigenetic mark at p ≤ 0.05 is shown (over-enrichment by default; under-enrichment is marked with asterisk; if both over- and under-enrichment were found for the same epigenetic
mark, only the dominant type is shown). bg-TNRs were predicted by Tandem Repeats Finder and stratified by sequence and/or genic region as per DA-TNRs.
a group of exceptions to this trend, amongst known repeat
expansion diseases. For all other tests, the average number of
cell types which are enriched for DNA methylation at DA-TNRs
exceeds 80%. This is interesting because DNAmethylation is also
observed in many repeat disease models, in particular upstream
of the repeat locus (Dion and Wilson, 2009; Kumari and Usdin,
2009).
Analysis of the histone markers revealed some surprising
aspects. We found active histone marks such as H3K4me3,
H3K4me1, H3K27ac, and H3K9ac are routinely enriched around
locations of many groups of DA-TNRs, in particular those
involving the repeat sequence CAG. To quantify their collective
enrichment, we refer to the union of all sites for each active mark.
Here, on average 27% of all cell types, across all sequence/region
permutations, are enriched for active marks (see Table 3, row
marked “Any” under section “Active marks”). This was strongest
for CAG and intronic repeats, and weakest for 3′ UTR and GCG
repeats. This is in contrast to disease models, where expanded
TNR loci are associated with silenced chromatin (Dion and
Wilson, 2009; Cohen-Carmon and Meshorer, 2012). Indeed, in
our analysis, the union of repressive marks displayed almost
complete lack of enrichment (see Table 3, row marked “Any”
under section “Repressive marks”). That DA-TNRs are enriched
for active marks prior to expansion suggest that they are lost in
that process. We also note that DNase I is statistically associated
with DA-TNRs, with an average of near 60% of cell types having
CAG DA-TNRs marked by DNase I at p < 0.05, across all genic
regions (Table 3).
3.2. Few Epigenetic Markers Display a
Significant Enrichment for Positional
Overlap with Disease Associated Triplets
To assess the epigenetic association of each individual DA-TNR,
we developed M2 (see Section 2) that compares the frequency of
overlap of the DA-TNR and the set of all bg-TNRs with the same
genic regions and sequence composition for a given epigenetic
mark. For example, the DA-TNR on chromosome X, at locus
66765160 (hg19) is a CAG repeat that is annotated as both exonic
and 3′ UTR (see Table 4 - AR). So, we define as background
the set of 36 CAG bg-TNRs that are both exonic and 3′ UTR
(according to NCBI-RefSeq). The bg-TNRs were then used to
determine the frequency of overlap with the epigenetic mark
(within 200 base pairs) across all cell types available for it.
For a specific epigenetic mark, we then asked the question:
can we explain the frequency of overlap between its occurrence
and that single DA-TNR locus across the cell types given the
distribution of observations in the corresponding set of bg-
TNRs? M2 uses the binomial test to evaluate if the DA-TNR
has a significantly different signature–by counting the number
of cell types in which it overlaps with the epigenetic mark.
The test makes two simplifying assumptions: that observations
in different cell types are independent, and that relationships
between an epigenetic mark and DA-TNRs can be found even
when the type of cell is disregarded. The latter violates our
biological understanding but allows individual DA-TNRs to be
profiled. With all cell types included in the test, the p-values were
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TABLE 4 | Over- and under-enriched epigenetic marks identified by M2 for individual DA-TNRs (see Figure 1).
Gene Name Locus R# Seq E I 5 3 H
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Sample
CODING, POLY-GLU REPEATS
AR X:66765160 34 CAG • ◦ ⇑ ⇑ ⇓ ⇑ ↑ 36
HTT 4:3076604 21 CAG • ⇑ ↓ ↓ ↑ ⇑ ⇑ 427
ATN1 12:7045880 20 CAG • ⇑ ⇑ ⇑ ↓ ⇑ ↓ ↑ 427
ATXN1 6:16327213 29 CAG • ◦ ↓ ⇓ ⇑ ↑ ↓ 45
ATXN2 12:112037083 23 CAG • ◦ ◦ ⇓ ↑ ↑ ↑ 7
ATXN3 14:92537280 27 CAG • ◦ ◦ ↓ 3
CACNA1A 19:13318283 13 CAG • ◦ ⇓ ⇑ 36
ATXN7 3:63898362 10 CAG • ◦ ⇑ ⇓ ↑ ⇑ ⇑ ⇑ 36
TBP 6:170870996 47 CAG • ⇑ ⇓ ↓ 427
KCNN3 1:154841700 17 CAG • ⇑ ⇑ ⇓ ⇑ ↑ 427
NCOA3 20:46279816 29 CAG • ↓ ⇓ ⇑ ↓ ↓ 427
CODING, POLY-ALA REPEATS
HOXD13 2:176957782 15 GCG • ⇑ ⇑ ↓ ⇓ 994
PABPN1 14:23790681 7 GCG • ◦ ⇓ ⇓ ⇑ 124
RUNX2 6:45390487 15 GCG • 994
ZIC2 13:100637703 18 GCG • ⇓ ⇑ ↓ 994
HOXA13 7:27238886 14 GCG • ⇑ ↑ ⇑ ↓ 994
FOXL2 3:138665094 14 GCG • ⇑ ⇑ 994
ARX X:25031140 15 GCG • ↑ ⇑ ↓ 994
CODING, POLY-ASP REPEATS
COMP 19:18896872 7 GAC • ↑ ↓ ⇑ 478
NON-CODING REPEATS
TCF4 18:53253401 24 CAG • ⇑ ⇑ ⇑ ⇑ ⇑ 760
DMPK 19:46273199 20 CAG • ↑ ⇑ ↓ ↑ ⇑ ⇑ 89
FXN 9:71652203 6 GAA • ⇑ ⇑ ↓ ⇑ ↑ ⇑ 3664
ATXN8OS 13:70681356 15 CAG ◦ • ⇑ ↓ ⇑ ⇓ ⇓ 48
PPP2R2B 5:146258400 11 CAG ◦ • ⇑ ⇑ 30
JPH3 16:87637894 14 CAG ◦ ⇑ ⇑ ⇑ ⇑ 785
MAB21L1 13:36050618 19 CAG ◦ • ↑ ⇑ ↑ ⇑ 30
RELN 7:103629939 8 GCG • ⇑ ⇓ 1354
FMR1 X:146993569 20 GCG ◦ • ◦ ↓ 13
FRA10AC1 10:95462158 8 GCG ◦ • 237
FMR2 X:147582153 19 GCG • ⇓ 1354
FAM11A X:148713314 12 GCG • 1354
CBL2 11:119077000 11 GCG • 1354
Columns include position in the reference genome (hg19; chromosome and locus), repeat tract length [R#] and [Seq]uence unit, if it occurs in an [E]xon (coding), [I]ntron, [5]′ or [3]′ UTR
regions (as annotated by RefSeq denoted by ◦; as reported in literature denoted by •). Enrichment of epigenetic marks is based on multiple cell types from the Roadmap Epigenomics
project and are assumed to be independent of cell type, relative bg-TNRs grouped by identical genic region and sequence composition. Arrows indicate over- (blue arrow) or under-
(red arrow) enrichment, at a corrected p ≤ 10–5 (single arrow) or p ≤ 10–10 (double arrow). The sample size of the background is shown in the column “Sample.” The lines separate
poly-Gln, poly-Ala, poly-Asp and non-coding repeats. See Supplementary Table 1 for disease identifiers. DNAm is DNA methylation.
corrected for multiple tests; the marks that were either over-
or under-enriched for the DA-TNR are shown in Table 4. (In
Table 4 arrows point up formore, arrows point down for less cell
types than expected.)
Our analyses revealed variation in the epigenetic state for
individual DA-TNRs across cell types does vary. Many, but
not all CAG DA-TNRs are enriched with H3K4me3, and less
consistently with H3K9ac andH3K27ac. DNAmethylation status
is not as clear for individual repeats, as it was when DA-TNRs
were viewed in groups. Four (of 32) individual DA-TNRs (all
exonic CAG) are under-enriched for methylation. The FXN
TNR is flagged as significantly DNA methylated, together with
H3K4me1, H3K4me3, H3K9ac, and H3K27ac. In general, this
still suggests that the epigenetic state in disease models (Al-
Mahdawi et al., 2008; Dion andWilson, 2009; Kumari and Usdin,
2009) are distinguishable from healthy cell types not in terms of
DNA methylation but in terms of the absence of histone marks
related to active and open chromatin (see Table 4).
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3.3. Enrichment of Other Epigenetic Marks
Around TNR loci
In addition to markers surveyed by the Roadmap Epigenomics
project, we also considered FAIRE (Giresi et al., 2007), which
measures DNA accessibility akin to DNase I hypersensitivity,
and the binding of factors such as histone deacetylases (HDAC).
This data are available from ENCODE (ENCODE Project
Consortium, 2012).
We established what factors and markers that are close to
disease linked TNR loci but not to other, comparable repeat
loci. Specifically, we developed M3 (see Section 2) to score co-
occurrence in terms of absolute genomic distance, designating
a mark as more strongly associated with a locus at an absolute
distance d, than a locus at a distance exceeding d (where
“absolute” means that we disregard if the mark is upstream or
downstream of the locus). By evaluating enrichment in terms of
distances we are able to apply a more sensitive test compensating
for the lack of cell types.
To ascertain the significance of the enrichment of each
epigenetic mark or factor at loci of DA-TNR, as before, we relied
on stratified bg-TNRs. We thus know, for each mark, how close
it is in general to a repeat, and could assign a p-value to indicate
the probability that the distance to the DA-TNR can be explained
by chance. Taken together, the distances and p-values for the 20
different epigenetic marks and factors, for each DA-TNR locus
are provided in the Supplementary Tables.
Table 5 again lists all known DA-TNRs, together with the
genomic regions they overlap with, and this time the marks
and factors we found to be significantly near to the locus of
the DA-TNR. We noticed that many DA-TNRs are enriched
for one or more marks, in general those indicating open
chromatin, DNA methylation and specific subsets of histone-
3 methylation–in agreement with the results rendered by the
overlap enrichment.
4. DISCUSSION
Across the range of normal, healthy cell types, we note that
several groups of DA-TNRs, and individual DA-TNRs appear in
H3K4 mono- and tri-methylated regions; in H3K9 and H3K27
acetylated regions (in particular CAG-repeats; see Table 3), all
of which are active marks and indicators of open chromatin
(Ernst et al., 2011). We also note that most DA-TNRs when
grouped are DNA methylated or at least close to methylated
CpGs (see Table 3). The latter observation is generally in line
with what is also observed in disease tissue, but the former is
not. We generally saw the same trends when using ZIP-seq data
as statistical background (see Supplementary Tables). Below we
make explicit reference to results based on bg-TNRs identified
using Tandem Repeats Finder, because they also cover non-CAG
repeats.
4.1. Interpreting the Enrichment of
Epigenetic Marks
The enrichment tests above indicate which cell type specific
epigenetic marks differ in their distribution around grouped
DA-TNRs when compared to a stratified background. This
is evidence that DA-TNRs have epigenetic features that are
relatively uncommon for stable TNRs. Statistically over- or
under-enriched factors in healthy tissues are key targets for future
analyses as they may be altered to either cause expansion, or as an
effect of expansion.
4.1.1. Chromatin Structure Around DA-TNRs
DNase I or FAIRE are effective markers for DNA accessibility,
and are often used to probe the chromatin packaging state. In
normal, healthy cells DA-TNRs tend to occur at loci overlapping
or proximal to DNase I hypersensitive tracts meaning that DNA
is accessible, as illustrated by Table 3 for groups of DA-TNRs
and Tables 4, 5 for individual DA-TNRs. FAIRE was proximity-
enriched at two DA-TNRs in hESC (see Table 5).
CTCF is a zinc-finger DNA binding protein that plays a role
in chromatin insulation, transcriptional regulation and genomic
imprinting. It affects higher order chromatin structure and
could therefore play a role in repeat instability, particularly in
the case of a binding site located 3′ to CAG repeats. Libby
et al. (2008) demonstrated this influence on stability at the
SCA7/ATXN7 locus and four other CAG repeat loci. We observe
that SCA7 and three other DA-TNRs have a CTCF binding site
significantly closer than expected by chance in hESC (see Table 5
and Supplementary Tables).
4.1.2. Absence of Repressive Histone Marks in
DA-TNRs
Three histone modifications (H3K27me3, H3K9me3, and
H4K20me1) are associated with a repressive or heterochromatic
environment. These marks were not prevalent around DA-TNRs
in normal cell types. The lack of repeats containing these marks
in the 758 epigenetic maps from the Roadmap Epigenomics
project and over 20 maps extracted from ENCODE’s hESC
(human embryonic stem cell) is in contrast with observations in
disease models (Al-Mahdawi et al., 2008; Dion andWilson, 2009;
Kumari and Usdin, 2009; Cohen-Carmon and Meshorer, 2012).
H3K27me3 and H3K36me3 are repressive marks associated
with disease models, but we failed to demonstrate a general
co-occurrence with DA-TNRs. They were over-enriched in a
small number of tissues and also significantly close to very
few DA-TNRs, but they also appeared to be under-enriched in
a few instances (see Table 3, section “Repressive marks”; also
see Table 5). H3K9me3 is also a repressive mark associated
with repetitive elements and constitutive heterochromatin (Al-
Mahdawi et al., 2008), but we failed to find a clear association
with DA-TNRs, with the exception of a weak over-enrichment
with GCG TNRs at 5′ UTR (see Table 3). H4K20me1 has
been linked to repression and transition to heterochromatin
and a number of biological processes including DNA damage
repair and DNA replication (Jørgensen et al., 2013). It was
only available for the ENCODE data set, but our analysis
indicated some support for linking it with DA-TNRs. Six
individual DA-TNRs showed significantly closer H4K20 mono-
methylation than what would be expected from observing bg-
TNRs.
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TABLE 5 | Proximity-enriched epigenetic marks in Human ESCs identified by M3 for individual DA-TNRs (see Figure 1).
Gene name Sequence Region Linked marker(s)
E I 5 3 Closer
CODING, POLY-GLU REPEATS
AR CAG • ◦ H4K20me1
HTT CAG • H3K4me3, H3K9ac
ATN1 CAG • H4K20me1
ATXN1 CAG • ◦ DNAm
ATXN2 CAG • ◦ ◦ DNAm
ATXN3 CAG • ◦ ◦
CACNA1A CAG • ◦ DNAm
ATXN7 CAG • ◦ CTCF
TBP CAG •
KCNN3 CAG • H3K9ac, HDAC2
NCOA3 CAG • H2az
CODING, POLY-ALA REPEATS
HOXD13 GCG •
PABPN1 GCG • ◦ H3K36me3, FAIRE
RUNX2 GCG • H2az
ZIC2 GCG • H3K36me3
HOXA13 GCG • DNase
FOXL2 GCG • CTCF
ARX GCG • DNase, FAIRE
CODING, POLY-ASP REPEATS
COMP GAC • H4K20me1
NON-CODING REPEATS
TCF4 CAG •
DMPK CAG • H4K20me1, HDAC2
FXN GAA • H2az, H3K27ac, H3K4me1, H3K4me2,
H3K4me3, H3K9ac, CTCF, DNase
ATXN8OS CAG ◦ • H3K4me1
PPP2R2B CAG ◦ • H3K27ac, DNase
JPH3 CAG ◦ H3K27me3, H3K79me2, HDAC2
MAB21L1 CAG ◦ • H4K20me1
RELN GCG • H3K20me1
FMR1 GCG ◦ • ◦
FRA10AC1 GCG ◦ • CTCF (x2), H3K4me3, H3K79me2,
H3K9ac
FMR2 GCG • H3K27me3
FAM11A GCG •
CBL2 GCG •
Columns include gene name and sequence unit, if it occurs in an [E]xon (coding), [I]ntron, [5]′ or [3]′ UTR regions (as annotated by RefSeq denoted by ◦; as reported in literature denoted
by •), and which epigenetic marks are significantly closer to DA-TNRs, relative bg-TNRs (p ≤ 0.05) in human ESCs.
4.1.3. DNA Methylation
DNA methylation plays a silencing role in gene expression,
chromatin structure and maintaining genome stability in
repetitive DNA (Robertson, 2002). DNA methylation patterns
have been shown to be very specific to cell types (Varley et
al., 2013) while histone modifications reflect changes in gene
transcription across cell types (Koch et al., 2007). Both M1
and M3 consider patterns of overlap and proximity in a cell
type specific manner, and are therefore capable to detect both
methylation and histone modification patterns. On the other
hand, M2 is only seeing an epigenetic signal for repeat loci if it
is independent of cell type. We therefore caution against over-
interpreting the enrichment of DNA methylation observed by
M2. This problem with M2 affects DNA methylation patterns
more than histone modifications, as methylation is more cell type
specific than histone modifications.
DNA methylation occurs at higher levels in CpGs upstream
of the GAA repeat and in some CpGs in the 5′ UTR in
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FIGURE 2 | The epigenetic environment of FRDA. A representation of epigenetic marks with their location around the Frataxin gene (NM_000144) across three
experimental data sets (named in the right margin). Upper panel: Marks are displayed if they are significantly close to the GAA repeat according to M3. Middle panel:
The full-width peaks for each mark around the GAA repeat according to the Roadmap Epigenome for healthy brain tissue. Lower panel: Changes in epigenetic marks
as observed in brain tissue, based on differences between normal and diseased state (Al-Mahdawi et al., 2008). Locations where DNAm and histone assays were
performed are shown. Arrows indicate a significant increase or decrease in methylation and histone binding at these locations. The size of the GAA repeat expansion
in the disease state is also indicated.
FXN (Evans-Galea et al., 2012), and with multiple other repeat
expansion models (Dion and Wilson, 2009). Several other
ataxia-related phenotypes (SCA1, SCA2, and SCA6) showed
close methylation patterns (see Table 4). It is striking that
DNA methylation is statistically enriched at sites of DA-TNRs
compared to genomically similar sites in a majority of tissues,
clearly suggesting that it is a feature of disease, but one which fails
to directly explain the transition of a repeat from a normal to an
expanded state. Speculatively, a transient state of de-methylation
could provide an explanation, as reduced methylation levels
are known to promote both contractions and expansions in
selected cell lines (Gorbunova et al., 2004). The DNAm states in
Figure 2 show that DNAmethylation is site specific with different
locations around the GAA repeat showing both increases and
decreases in DNA methylation of CpGs. This variation seconds
the idea of transience in the methylation state around unstable
TNRs.
The key hypothesis that can be drawn from the above
observations is that DA-TNRs are located in an epigenetic
environment enriched for markers of open chromatin and active
regulation making them susceptible to histone modifications
introducing repressive marks, alterations to the chromatin
landscape, transcience in methylation state and, ultimately,
repeat expansion mutations.
Overall these findings suggest that transcriptionally active
regions that harbor repeats may be more prone to DNA
mutations thus increasing the propensity of repeats to undergo
expansions. For instance, it has been shown that transcriptionally
active chromatin recruits homologous recombination at DNA
double strand-breaks (Aymard et al., 2014). Homologous
recombination is one such mechanism that has been previously
suggested to contribute to the expansion of repeats (Zhou et al.,
2001).
4.2. Application of Results to a Disease
Model
Friedreich ataxia (FRDA) is a loss-of-function disease caused
by an expanded intronic GAA repeat in the Frataxin (FXN)
gene, and in our analysis it displayed the greatest number
of epigenetic marks in its distance profile (see Table 5).
Figure 2 indicates the approximate location of these marks
as assayed in hESCs and brain tissue, and as observed in
disease models, from the data we analyzed and the experimental
literature, respectively. The marks from hESCs and brain tissue
contribute to an open chromatin environment and indicate a
proximal active promoter (Ernst et al., 2011). In combination,
they show that epigenetic marks identified as significant in
hESCs are also observed near the GAA repeat in a tissue-
specific sample including H3K9ac, H3K27ac, H3K4me1, and
H3K4me3. An alteration to histone-3, lysine-9, and lysine-
27 from acetylation to repressive tri-methylation modifications
would cause a transition to a repressive heterochromatic
environment (Hahn et al., 2010). In the third set of factors
in Figure 2 from diseased brain tissue, the alteration from
H3K9ac to H3K9me can be observed. Significant variations in
methylation, a loss of H3K9 acetylation and increase in H3K9
methylation around the GAA repeat and 5′ UTR all indicate
a repressive heterochromatic environment in the disease state.
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Based on our statistical analyses of epigenetic marks around
the repeat, specific hypotheses can be drawn to address this
transition. For example, this is consistent with the findings that
suggest that the inhibitors of histone deacetylase increase FXN
expression levels (Herman et al., 2006). It would be interesting
to assess whether blocking histone methyl transferase to prevent
H3K9ac and H3K27ac would promote the stability of the GAA
repeat.
5. CONCLUSION
We note that DA-TNRs are placed in regions ranging from
5′ to 3′ UTR, in exons and introns. While epigenetic states
tend to vary widely between such regions and tissues, we have
observed consistency of epigenetic states around DA-TNRs that
are not associated with bg-TNRs. Since our comparisons are
stratified, this consistency of epigenetic state can hypothetically
be attributed to the shared biological circumstance–that of
expanding under some yet unknown condition.
By using the breadth and depth of DNA and chromatin
state data we were able to determine statistical enrichment of
epigenetic marks around a repeat expansion locus and to provide
qualified support for observations relevant to mechanisms
behind repeat expansion itself. However, there are several caveats
to what can come out of such analyses. While research has been
conducted to investigate the changes in the surrounding genomic
context of repeats, how the chromatin structure directly relates to
repeat, is still unresolved. Cultured cells and transgenic models
provide clues to epigenetic states of repeat expansions, but it
is well acknowledged these cells can develop non-physiological
epigenetic profiles (Al-Mahdawi et al., 2008). This paper develops
a complementary resource for understanding epigenetic states
under normal conditions, and a group of methods that when
disease tissue becomes available enable the analysis of the
epigenetic states linked to repeat instability.
Our statistical analyses brings the scale of epigenetic data
offered by recent technologies to bear, to identify a handful
of what appear significant epigenetic markers that should be
assayed with priority in disease tissues, in particular DNA
methylation, H3K4me3, H3K9, and H3K27 acetylation, DNase
I hypersensitivity and HDAC. We also note that our analyses
support the development of signatures that can be used to
identify new repeat loci, with potential to expand.
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